Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: Human megakaryocytic leukaemia cells are non-permissive for AAV infection

Journal of General Virology

Volumn 77, Issue 6, 1996, Pages 1111-1122

  Ponnazhagan, Selvarangan ^a   Wang, Xu Shan ^a   Woody, Michael J ^a   Luo, Feng ^a   Kang, Li Ya ^a   Nallari, Madhavi L ^a   Munshi, Nikhil C ^b   Zhou, Shang Zhen ^a   Srivastava, Arun ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; PARVOVIRUS;

LUCIFERASE;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN KB; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS INFECTIVITY; VIRUS RECOMBINANT;

CELL DIFFERENTIATION; CYTOMEGALOVIRUS; DEPENDOVIRUS; GENETIC VECTORS; HELA CELLS; HUMANS; KB CELLS; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; LUCIFERASES; PARVOVIRUS B19, HUMAN; PLASMIDS; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; RESTRICTION MAPPING; SIMIAN VIRUS 40; TRANSFECTION; TUMOR CELLS, CULTURED; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0029934455     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-6-1111     Document Type: Article

References (49)

1. ANDERSON, M. J., JONES, S. E., FISHER-HOCH, S. P., LEWIS, E., HALL, S. M., BARTLETT, C. L. R., COHEN, B. J., MORTIMER, P. P. & PEREIRA, M. S. (1983). Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet i, 1378.
2. ANDERSON, M. J., HIGGINS, P. G., DAVIS, L. R., WILLIAMS, J. S., JONES, S. E , KIDD, I. M., PATTISON, J. R & TYRELL, D. A. J. (1985). Experimental parvoviral infection in humans. Journal of Infectious Diseases 62, 257-265.
3. BLUNDELL, M. C., BEARD. C. & ASTELL, C. R. (1987). In vitro identification of a B19 parvovirus promoter. Virology 157, 534-538.
4. BROWN, T. A , ANAND, A., RITCHIE, L. D., CLEWLEY, J. P & REID, T. M. S. (1984). Intrauterine parvovirus infection associated with hydrops fetalis. Lancet ii, 1033-1034.
5. BROWN, K. E., ANDERSON, S. M & YOUNG, N. S. (1993) Erythrocyte P antigen: cellular receptor for B19 parvovirus Science 262, 114-117
6. BROWN, K. E., YOUNG, N. S. & LIU, J. M. (1994). Molecular, cellular and clinical aspects of parvovirus B19 infection. Critical Reviews in Oncology and Hematology 16, 1-31.
7. COSSART, V. E., FIELD, A M., CANT, B. & WIDDOWS, D. (1975). Parvovirus like particles in human sera. Lancet i, 72-73.
8. CURIEL, D. T., WAGNER, E., COTTEN, M., BIRNSTIEL, M. L., AGARWAL, S., LI, C.-M. & HU, P.-C. (1992). High-efficiency gene transfer mediated by adenovirus coupled to DNA-potylysine complexes Human Gene Therapy 3, 147-154.
9. DEWET, J. R., WOOD, K. V., DELUCA, M., HELSINKI, D. R & SUBRAMANI. S (1987). Firefly hiciferase gene: structure and expression in mammalian cells. Molecular and Cellular Biology 7, 725-737.
10. DOERIG, C., BEARD, P. & HIRT, B. (1987). A transcriptional promoter of the human parvovirus B19 active in vitro and in vivo. Virology 157, 539-542.
11. DOERIG, C., HIRT, B., ANTONIETTI, J. P. & BEARD, P. (1990). Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. Journal of Virology 64, 387-396.
12. HENDRIE, P. C., MIYAZAWA, K., YANG, Y.-C., LANGEFELD, C. D. & BROXMEYER, H. E. (1991). Mast cell growth factor (c-kit ligand) enhances stimulation of proliferation of human factor dependent cell line M07e. Experimental Hematology 19, 1031-1037.
13. HIRT, B. (1967). Selective extraction of polyoma DNA from infected mouse cultures. Journal of Molecular Biology 26, 365-369.
14. KURTZMAN, G J., OZAWA, K., COHEN, B. J., HANSEN, G. R., OSEAS, R. & YOUNG, N. S. (1986). Chronic bone marrow failure due to persistent B19 parvovirus infection. New England Journal of Medicine 317, 287-293.
15. LIU, J. M., FUJII, M., GREEN, S. W., KOMATSU, N., YOUNG, N. S. & SHIMADA, T. (1991). Indiscriminate activity from the B19 parvovirus p6 promoter in non-permissive cells Virology 182, 361-364.
16. LIU, J. M., GREEN, S. W., SHIMADA, T. & YOUNG, N. S. (1992). A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. Journal of Virology 66, 4686-4692.
17. LUO, F., ZHOU, S. Z., COOPER, S., MUNSHI, N. C., BOSWELL, H. S., BROXMEYER, H. E. & SRIVASTAVA, A. (1995). Adeno-associated virus 2-mediated gene transfer and functional expression of the human granulocyte-macrophage colony-stimulating factor. Experimental Hematology, 23, 1261-1267.
18. MORGAN, D. A., GUMUCHIO, D. L. & BRODSKY, I. (1991). Granulocytemacrophage colony-stimulating factor dependent growth and erythropoietin-induced differentiation of a human cell line MB-02. Blood 78, 2860-2871.
19. MUNSHI, N. C., ZHOU, S. Z, WOODY, M. J., MORGAN, D. A. & SRIVASTAVA, A. (1993). Successful replication of parvovirus B19 in the human megakaryocytic leukemia cell line MB-02. Journal of Virology 67, 562-566.
20. MUZYCZKA, N. (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Current Topics in Microbiology and Immunology 158, 97-129.
21. NAHREINI, P. & SRIVASTAVA, A. (1989). Rescue and replication of the adeno-associated virus 2 genome in mortal and immortal human cells. Intervirology 30, 74-85.
22. NAHREINI, P. & SRIVASTAVA, A. (1992). Rescue of the adeno-associated virus 2 genome correlates with alterations in DNA-modifying enzymes in human cells. Intervirology 33, 109-115.
23. NAHREINI, P., WOODY, M J., ZHOU, S. Z. & SRIVASTAVA, A. (1993). Versatile adeno-associated virus 2-based vectors for constructing recombinant virions. Gene 124, 257-262.
24. OZAWA, K., KURTZMAN, G J. & YOUNG, N. S. (1986). Replication of the B19 parvovirus in human bone marrow cultures. Science 233, 883-886
25. OZAWA, K., AYUB, J., YU-SHU, H., KURTZMAN, G. J., SHIMADA, T. & YOUNG, N. S (1987a). Novel transcription map for the B19 (human) pathogenic parvovirus Journal of Virology 61, 2395-2406
26. OZAWA, K., KURTZMAN, G. J. & YOUNG, N. S. (1987b). Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 70, 384-391.
27. PATTISON, J. R., JONES, S. E., HODGESON, J., DAVIS, L R , WHITE, J. M., STROUD, C. E. & MURTAZA, L. (1981). Parvovirus infection and hypoplastic crisis in sickle cell disease. Lancet 1, 664-665.
28. PONNAZHAGAN, S, NALLARI, M. L. & SRIVASTAVA, A. (1994). Suppression of human x-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors. Journal of Experimental Medicine 179, 733-738.
29. PONNAZHAGAN, S., WOODY, M J., WANG, X.-S., ZHOU. S Z & SRIVASTAVA, A. (1995). Transcriptional transactivation of parvovirus B19 promoters in non-permissive human cells by adenovirus type 2. Journal of Virology 69, 8096-8101.
30. SAARINEN, U M., CHORBA, T. L., TATTERSALL, P., YOUNG, N. S., ANDERSON, L. J., PALMER. E. & COCCIA, P.P. (1986). Human parvovirus B19 induced epidemic red cell aplasia in patients with hereditary hemolytic anemia. Blood 67, 1411-1417.
31. SAMULSKI, R. J., CHANG, L.-S. & SHENK, T. (1987). A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. Journal of Virology 61, 3096-3101.
32. SAMULSKI, R. J., CHANG, L.-S. & T. SHENK. (1989). Helper-free stocks of recombinant adeno-associated viruses : normal integration does not require viral gene expression. Journal of Virology 63, 3822-3828.
33. SCHWARZ, T. F., SERKE, S., HOTTENTRAGER, B., VON BRUNN, A., BAURMANN, H., KIRSCH, A., STOLZ, W., HUNN, D., DEINHARDT, F. & ROGGENDROF, M. (1992). Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood. Journal of Virology 67, 562-566.
34. SERJEANT, G. R., MASON, K., TOPLEY, J. M., SERJEANT, B. M., PATTISON, J. R., JONES, S. E. & MOHAMED, R. (1981). Outbreak of aplastic crisis in sickle cell anemia associated with parvovirus-like agent. Lancet ii, 595-597.
35. SHADE, R. O., BLUNDELL, M. C., COTMORE, S. F., TATTERSALL, P. & ASTELL, C. R. (1986). Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. Journal of Virology 58, 921-936.
36. SHIMOMURA, S., KOMATSU, N., FRICKHOFEN, N., ANDERSON, S., KAJIGAYA. S. & YOUNG, N. S. (1992). First continuous propagation of B19 parvovirus in a cell line. Blood 79, 18-24.
37. SPALHOLZ, B A. & TATTERSALL, P. (1983). Interaction of minute virus of mice with differentiated cells: strain dependent target-cell specificity is mediated by the intracellular factors. Journal of Virology 46, 937-943.
38. SRIVASTAVA, A. (1987). Replication of the adeno-associated virus DNA termini in vitro. Intervirology 27, 138-147.
39. SRIVASTAVA, A. & LU, L. (1988). Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. Journal of Virology 62, 3059-3063.
40. SRIVASTAVA, C. H., SAMULSKI, R. J., LU, L., LARSEN, S. H. & SRIVASTAVA, A. (1989). Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus. Proceedings of the National Academy of Sciences, USA 86, 8078-8082.
41. SRIVASTAVA, A., BRUNO, E., BRIDDELL, R., COOPER, R., SRIVASTAVA, C. H., VAN BESIEN. K., & HUFFMAN, R. (1990). Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 76, 1997-2004.
42. SRIVASTAVA, C. H., ZHOU, S. Z., MUNSHI, N. C. & SRIVASTAVA, A. (1992). Parvovirus B19 replication in human umbilical cord blood cells. Virology 189, 456-461.
43. TUAN, D. Y H., SOLOMON, W. B., LONDON, I. M. & LEE, D P. (1989). An erythroid specific, development stage-independent enhancer far upstream of the human 'β-like globin' genes. Proceedings of the National Academy of Sciences, USA 86, 2554-2559
44. WALSH, C. E., LIU, J. M., XIAO, X., YOUNG, N. S., NIENHUIS, A. W. & SAMULSKI, R. J. (1992). Regulated high level expression of a human γ-globin introduced into erythroid cells by an adeno-associated virus vector. Proceedings of the National Academy of Sciences, USA 89, 7257-7261.
45. WANG, X-S., M. C. YODER, S. Z. ZHOU & A. SRIVASTAVA. (1995). Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells. Proceedings of the National Academy of Sciences, USA 92, 12416-12420.
46. YAEGASHI, N , SHIRAISHI, H., TAKESHITA, T., NAKAMURA, M., YAJIMA, A. & SUGAMURA, K. (1989). Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. Journal of Virology 63, 2422-2426.
47. ZHOU, S. Z., BROXMEYER, H. E., COOPER, S., HARRINGTON, M. A. & SRIVASTAVA, A. (1993). Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Experimental Hematology 21, 928-933.
48. ZHOU, S. Z., COOPER, S., KANG, L. Y., RUGGIERI, L., HEIMFELD, S., SRIVASTAVA, A. & BROXMEYER, H. E. (1994). Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. Journal of Experimental Medicine 179, 1867-1875.
49. ZHOU, S. Z., LI, Q., STOMATOYANNOPOULOS, G. & SRIVASTAVA, A (1996). Adeno-associated virus 2-mediated transduction and erythroid cell-specific expression of a normal human β-globin gene. Gene Therapy (in press).